Sanofi, Pharmaceutical company

French pharma major Sanofi said on Friday it has decided to donate 100 million doses of hydroxychloroquine, the anti-malaria drug which could be a potential weapon against novel coronavirus, across 50 countries.The company has already doubled its incremental production capacity on top of the usual production for current indications across its eight hydroxychloroquine manufacturing sites worldwide and is on track to quadruple it by the summer."In this global health emergency, Sanofi stands ready to assist as many countries as possible, starting with countries where its medicine is registered for current approved indications as well as countries where there are no hydroxychloroquine suppliers or countries with underserved populations," it said in a statement.Sanofi called for coordination among the entire hydroxychloroquine chain worldwide to ensure the continued supply of the medicine if proven to be a well-tolerated and effective treatment in COVID-19 patients."The COVID-19 pandemic is an unprecedented health and economic crisis which is shaking some of the very fundamentals of international solidarity and cooperation among countries," said Chief Executive Officer Paul Hudson. "This virus does not care about the concept of borders, so we should not either," he added."It is critical that international authorities, local governments, manufacturers and all other players involved in the hydroxychloroquine chain work together in a coordinated manner to ensure all patients who may benefit from this potential treatment can access it. If the trials prove positive, we hope our donation will play a critical role for patients," said Hudson.While hydroxychloroquine is generating a lot of hope for patients around the world, said Sanofi, it should be remembered that there are no results from ongoing studies and the results may be positive or negative.To date, there is insufficient clinical evidence to draw any conclusion over the safety and efficacy of hydroxychloroquine in the management of COVID-19 patients.It is one of several medicines being investigated by the World Health Orgsation (WHO) in its international clinical trial seeking a treatment solution for COVID-19. "Sanofi is supporting ongoing trials by providing the medicine to some participating investigator sites and other independent research centres," it said.( With inputs from ANI )

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Lok Sabha Election 2024

Heatwave In India

Mumbai Water Cut

Maharashtra Lok Sabha Election

IPL 2024

Salman Khan

SanofiFOLLOW

Sanofi, Latest News

Health :DGCI nod for Sanofi-GSK's phase 3 trial of Covid vax in India

Mumbai, July 8 The Drugs Controller General of India (DGCI) has granted approval to Sanofi and Glaxo Smith ... ...

International :Mexico to conduct clinical trials of Walvax, Sanofi Vaccines: Foreign Secretary

Mexico intends to conduct clinical trials of vaccines against COVID-19 developed by China's Walvax and France's Sanofi, Foreign Secretary Marcelo Ebrard said. ...

International :Sanofi, GSK start phase 2 trial of their COVID-19 vaccine, phase 3 could begin by April

Sanofi and GlaxoSmithKline (GSK) said on Monday they had begun a phase 2 trial of their COVID-19 vaccine candidates, and if results are positive, a phase 3 study could start in the second quarter of 2021. ...

Health :Sanofi, GSK start human trial of their Covid-19 vaccine

Paris, Sep 3 Pharmaceutical giants Sanofi and Glaxo Smith Kline (GSK) on Thursday started a clinical trial for ... ...

Business :Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries

French pharma major Sanofi said on Friday it has decided to donate 100 million doses of hydroxychloroquine, the anti-malaria drug which could be a potential weapon against novel coronavirus, across 50 countries. ...